Previous 10 | Next 10 |
May 1, 2020 Palm Beach, FL – May 1, 2020 – America’s public-private sector collaboration on the global health crisis appears to have borne fruit… very quickly. The government has streamlined regulations and the public sector has responded with unheard o...
Mesoblast Limited (NASDAQ: MESO ) announces the start of enrollment in a Phase 2/3 clinical trial evaluating allogeneic mesenchymal stem cell candidate remestemcel-L in COVID-19 patients with moderate-to-severe acute respiratory distress syndrome. More news on: Mesoblast Limited, Healthc...
NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic mesenchymal stem cell therapy r...
NeuBase Therapeutics (NASDAQ: NBSE ) -15% on equity offering . More news on: NeuBase Therapeutics, Inc., Yield10 Bioscience, Inc., Blueprint Medicines Corporation, Stocks on the move, , Read more ...
April 28, 2020 Palm Beach, FL – April 28, 2020 – The U.S. Federal government is working closely with companies and researchers to find treatments and vaccines to overcome the global health crisis. The FDA has been cutting red tape and has launched new programs that r...
Medical professionals would surely welcome any safe and effective treatment option for people with COVID-19 -- and pharmaceutical companies are doing their best to hastily find solutions. Preclinical and clinical trials now under way are testing seemingly every plausible hypothesis, from failed ...
Shares of Mesoblast (NASDAQ: MESO) fell as much as 22.3% today as investors decided to lock in gains. The stem-cell stock erupted for a 139% gain on Friday after data from a small study suggested the company's cell therapy might significantly improve outcomes for COVID-19 patients placed on ...
Gainers: Yield10 Bioscience (NASDAQ: YTEN ) +68% . More news on: Yield10 Bioscience, Inc., Aytu BioScience, Inc., Avadel Pharmaceuticals plc, Stocks on the move, , Read more ...
Although the COVID-19 pandemic hasn't been kind to most equities this year, some biotech and healthcare stocks have gotten a huge boost from this deadly respiratory illness. In particular, a select group of companies working on experimental COVID-19 vaccines and therapies have seen their share p...
CNX Midstream Partners LP (NYSE: CNXM ) -31% on dividend cut . More news on: CNX Midstream Partners LP, Verastem, Inc., Whiting Petroleum Corporation, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 14:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for MESO on July 23, 2024 12:57PM ET. MESO was trading at $8.29 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 5 - Buy, 2 - H...
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) resubmission for...
NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the confirmatory Phase 3 trial of its allogeneic, immunoselected, and industrially manufactured stromal cell product...